Menu
  • Home
  • London Exchange
  • Euronext
  • Australian Exchange
  • Wire
  • Contact Us
  • Business & Finance
NewsnReleases

Kit Check and Sandoz to launch RFID-tagged generic injectables in October 2020

Posted on October 2, 2020October 2, 2020
Kit Check and Sandoz to launch RFID-tagged generic injectables in October 2020 1
Both Sandoz and Kit Check are members of the newly formed industry consortium, DoseID, that certifies interoperable and high performing RFID technology in the healthcare space.

WASHINGTON: Kit Check in collaboration with Sandoz announced that two Radio Frequency Identification (RFID)-tagged injectable generic Sandoz products will be available in United States hospitals in October 2020.

The first two medicines include Anectine 200 mg/10mL and Rocuronium 50mg/5mL and 10mg/5mL. Several more Sandoz medicines are expected to be made available pre-tagged with DoseID compliant RFID tags for Kit Check hospital partners through early 2021.

Both Sandoz and Kit Check are members of the newly formed industry consortium, DoseID, which certifies interoperable and high performing RFID technology in the healthcare space.

Medications labeled with RFID tags at the manufacturer level ensures that there is item-level visibility of drug products throughout their dynamic lifecycle. This means better patient safety, optimized inventory for hospitals, cost savings, and dramatically increased workflow simplicity and efficiency.

RFID tags store important information for each dose, including expiration date, lot number, NDC, and refrigeration date, so restocking, inventory management, and managing shortages and recalls is as seamless as possible. COVID-19 has continued to shine a light on the importance of item-level inventory management in the hospital, with Kit Check customers well poised to deal with the difficulty inventory challenges the pandemic has caused.

“We are so excited to be able to offer RFID-tagged generics for our hospital customers, and even more excited to be working with Sandoz on such a momentous launch,” said Kevin MacDonald, CEO and Co-Founder of Kit Check. “This is a pivotal moment for the industry and most importantly our hospital customers who can enjoy all the benefits of RFID-tagged medications, without the tagging labor. COVID-19 has made it all the more clear just how important it is to be able to keep an eye on each and every dose of medication in the hospital, and we are pleased to have joined forces with Sandoz on a real solution.”

Kit Check is the leading provider of automated medication tracking and diversion detection solutions for hospital pharmacies in the U.S., bringing visibility, simplicity, and predictability to the complex world of medication supply management.

www.kitcheck.com

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Track all markets on TradingView

Investing.com .

Site Navigation

  • Home
  • Listed Companies
  • Contact Us
  • London Stock Exchange
  • Singapore Exchange
  • Canadian Exchange
  • Australian Exchange
  • Oslo Bourse
  • PSX
  • Ratings
  • Euronext
  • MENA
  • Nasdaq Nordic
  • Wire
  • Business & Finance
  • Gadget Reviews
  • About Us: A Comprehensive Financial News Database

All news and articles on NewsnReleases are based on press releases, corporate announcements and analysts’ reports issued to London Stock Exchange (LSE), Euronext, Singapore Exchange (SGX), Japan Stock Exchange (JPX), Dubai Financial Market (DFM), Saudi Stock Exchange (Tadawul), Qatar Stock Exchange (QSE), BSEIndia, Australia Stock Exchange etc.

Listed Companies

Equity Markets and Stock Exchanges

NNR

©2025 NewsnReleases | WordPress Theme by Superb WordPress Themes